 Q BioMed Inc. OTCQB:QBIO told shareholders that the company was seeing a significant uptrend in revenues, advancing its pipeline of assets, and was looking at an imminent up listing to the tech-dominated Nasdaq. The New York-based commercial-stage biotech company has engaged EVERSANA, which provides commercial services, to support the commercialization of Strontium89. 